突变
计算生物学
抗体
亲和力成熟
化学
理论(学习稳定性)
功能(生物学)
蛋白质稳定性
计算机科学
可扩展性
蛋白质工程
突变
过程(计算)
药品
组合化学
订单(交换)
定向进化
蛋白质结构
比例(比率)
药物发现
表型
生物
作者
Ariel Tennenhouse,Adva Mechaly,Tony Pham,Robert J. Oldham,Jake Y. Henry,Dorry X. Zhao,Thomas M. Moon,Isabel G Elliott,Omri Porat,Jinny Kim,Yael Fridmann Sirkis,Sveta Gaiduk,Itay Talpir,Jamie Bird,Christopher Domalewski,Pei-Hsuan Chu,Andrew B. Dippel,Rebecca Croasdale-Wood,Daniel Christ,Gilad Kaplan
标识
DOI:10.1038/s41467-026-78946-3
摘要
Affinity maturation is an essential process in antibody engineering. Although powerful, it is iterative, time-consuming, and can result in trade-offs, where affinity is gained at the cost of important properties, such as specificity and stability. We present a scalable strategy, called LAffAb, that starts from a crystallographic structure of the antibody-antigen complex and introduces combinations of mutations to optimize its energy. A combinatorial library comprising 7,000 variants with up to nine mutations results in gains of up to 30-fold in affinity while co-optimizing stability. Surprisingly, the library does not converge on a single solution, instead favoring diverse variants with a high mutational load. Small-scale screening of 10 designs against a potential drug target results in an order-of-magnitude improvement in affinity while maintaining high developability. We also apply LAffAb to improve the developability of a therapeutic antibody without degrading affinity. We envision that LAffAb can be used to design stable, specific, and high-affinity binders and to improve our understanding of sequence, structure, and function relationships in antibodies.
科研通智能强力驱动
Strongly Powered by AbleSci AI